Matches in DBpedia 2015-10 for { ?s ?p "Stephen H. Friend MD PhD (born December 10, 1953) is an American physician, scientist, entrepreneur and innovator. He is an authority in the field of cancer biology and a pioneer in the field of the genetics of gene expression, integrating system biology approaches to complex diseases. He is the president, co-founder and director of Sage Bionetworks, a Seattle-based non-profit organization founded in 2009, that provides the tools and environment to conduct dynamic, large-scale biomedical research transparently and collaboratively.Friend believes that successful biomedical research requires the active participation from all stakeholders. He is reimagining the role of citizens in the research process as equal partners with researchers and is building tools to empower them to contribute both their data and expertise as they see fit. He wants to break down the cultural barriers that hamper progress in research and is a strong advocate for open science. Dr. Friend is actively engaging the community to crowd-source solutions to complex biomedical questions through targeted open DREAM analysis challenges. In March 2014 Dr. Friend and Dr. Eric Schadt announced the launch of the Resilience Project, a new crowdsourced effort to understand how people with high risk of developing serious genetic diseases have stayed healthy, and possibly discover the “genetic decoder ring” that protect and prevent diseases.Previously Senior Vice-President and Franchise Head for Oncology Research at Merck & Co. Dr. Friend led Merck’s Basic Cancer Research efforts. Prior to that Dr. Friend co-founded Rosetta Inpharmatics with Leland H. Hartwell and Leroy Hood in 1996 Much of his research has focused on cancer."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- Stephen_Friend abstract "Stephen H. Friend MD PhD (born December 10, 1953) is an American physician, scientist, entrepreneur and innovator. He is an authority in the field of cancer biology and a pioneer in the field of the genetics of gene expression, integrating system biology approaches to complex diseases. He is the president, co-founder and director of Sage Bionetworks, a Seattle-based non-profit organization founded in 2009, that provides the tools and environment to conduct dynamic, large-scale biomedical research transparently and collaboratively.Friend believes that successful biomedical research requires the active participation from all stakeholders. He is reimagining the role of citizens in the research process as equal partners with researchers and is building tools to empower them to contribute both their data and expertise as they see fit. He wants to break down the cultural barriers that hamper progress in research and is a strong advocate for open science. Dr. Friend is actively engaging the community to crowd-source solutions to complex biomedical questions through targeted open DREAM analysis challenges. In March 2014 Dr. Friend and Dr. Eric Schadt announced the launch of the Resilience Project, a new crowdsourced effort to understand how people with high risk of developing serious genetic diseases have stayed healthy, and possibly discover the “genetic decoder ring” that protect and prevent diseases.Previously Senior Vice-President and Franchise Head for Oncology Research at Merck & Co. Dr. Friend led Merck’s Basic Cancer Research efforts. Prior to that Dr. Friend co-founded Rosetta Inpharmatics with Leland H. Hartwell and Leroy Hood in 1996 Much of his research has focused on cancer.".